Anita Rachlis

10.4k total citations · 2 hit papers
135 papers, 4.1k citations indexed

About

Anita Rachlis is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Anita Rachlis has authored 135 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Infectious Diseases, 64 papers in Epidemiology and 38 papers in Virology. Recurrent topics in Anita Rachlis's work include HIV/AIDS Research and Interventions (57 papers), HIV/AIDS drug development and treatment (42 papers) and HIV Research and Treatment (37 papers). Anita Rachlis is often cited by papers focused on HIV/AIDS Research and Interventions (57 papers), HIV/AIDS drug development and treatment (42 papers) and HIV Research and Treatment (37 papers). Anita Rachlis collaborates with scholars based in Canada, United States and United Kingdom. Anita Rachlis's co-authors include Sharon Walmsley, Nancy Ruíz, Karen T. Tashima, Daniel J. Skiest, Schlomo Staszewski, Richard Stryker, Douglas J. Manion, James Stanford, Javier O Morales-Ramirez and Philip C. Johnson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Blood.

In The Last Decade

Anita Rachlis

133 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults

1999 788 citations Anita Rachlis et al. profile →
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

2013 404 citations François Raffi, Anita Rachlis et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anita Rachlis Canada	31	2.6k	1.6k	1.6k	719	280	135	4.1k
Carol A. Kemper United States	35	2.7k 1.0×	2.0k 1.2×	1.0k 0.6×	506 0.7×	381 1.4×	82	4.2k
Sundhiya Mandalia United Kingdom	42	2.9k 1.1×	1.6k 1.0×	1.6k 1.0×	851 1.2×	600 2.1×	157	5.7k
Princy Kumar United States	30	2.7k 1.0×	1.4k 0.8×	1.7k 1.1×	751 1.0×	219 0.8×	127	3.8k
Adriana Ammassari Italy	37	2.9k 1.1×	1.5k 0.9×	1.5k 1.0×	838 1.2×	385 1.4×	126	5.0k
Daniel J. Skiest United States	35	2.5k 0.9×	1.6k 1.0×	1.2k 0.8×	563 0.8×	97 0.3×	100	3.9k
Amy Weintrob United States	34	1.6k 0.6×	1.6k 1.0×	1.1k 0.7×	696 1.0×	128 0.5×	98	4.0k
Carsten Schade Larsen Denmark	33	2.0k 0.8×	1.2k 0.7×	1.1k 0.7×	1.4k 2.0×	184 0.7×	176	4.0k
Mallory D. Witt United States	37	2.7k 1.0×	1.7k 1.1×	1.6k 1.0×	1.7k 2.4×	266 0.9×	138	4.8k
Jan W. Mulder Netherlands	47	3.5k 1.3×	1.2k 0.7×	2.9k 1.8×	618 0.9×	158 0.6×	159	6.3k
Kevin J.P. Craib Canada	36	2.2k 0.8×	2.0k 1.2×	948 0.6×	557 0.8×	691 2.5×	79	4.3k

Countries citing papers authored by Anita Rachlis

Since Specialization

Citations

This map shows the geographic impact of Anita Rachlis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anita Rachlis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anita Rachlis more than expected).

Fields of papers citing papers by Anita Rachlis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anita Rachlis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anita Rachlis. The network helps show where Anita Rachlis may publish in the future.

Co-authorship network of co-authors of Anita Rachlis

This figure shows the co-authorship network connecting the top 25 collaborators of Anita Rachlis. A scholar is included among the top collaborators of Anita Rachlis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anita Rachlis. Anita Rachlis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Raboud, Janet, Jill Tinmouth, Sean B. Rourke, et al.. (2017). Gastrointestinal Symptom Distress is Associated With Worse Mental and Physical Health-Related Quality of Life. JAIDS Journal of Acquired Immune Deficiency Syndromes. 75(1). 67–76. 5 indexed citations

Palmay, Lesley, Marion Elligsen, Sandra A N Walker, et al.. (2014). Hospital-wide Rollout of Antimicrobial Stewardship: A Stepped-Wedge Randomized Trial. Clinical Infectious Diseases. 59(6). 867–874. 39 indexed citations

Raffi, François, Anita Rachlis, Hans‐Jürgen Stellbrink, et al.. (2013). Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study. The Lancet. 381(9868). 735–743. 404 indexed citations breakdown →

Gogolishvili, David, Sergio Rueda, Jason Brunetta, et al.. (2013). Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS. AIDS. 27(15). 2385–2401. 77 indexed citations

Gillis, Jennifer, Curtis Cooper, Sean B. Rourke, et al.. (2012). Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals. Quality of Life Research. 22(7). 1525–1535. 21 indexed citations

Raboud, Janet, Maggie Li, Sharon Walmsley, et al.. (2010). Once Daily Dosing Improves Adherence to Antiretroviral Therapy. AIDS and Behavior. 15(7). 1397–1409. 25 indexed citations

Loutfy, Mona, Miguel Genebat, David J. Moore, et al.. (2010). A CD4+ Cell Count <200 Cells per Cubic Millimeter at 2 Years After Initiation of Combination Antiretroviral Therapy Is Associated With Increased Mortality in HIV-Infected Individuals With Viral Suppression. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(4). 451–459. 39 indexed citations

Loutfy, Mona, Trevor Hart, Saira Mohammed, et al.. (2009). Fertility Desires and Intentions of HIV-Positive Women of Reproductive Age in Ontario, Canada: A Cross-Sectional Study. PLoS ONE. 4(12). e7925–e7925. 134 indexed citations

Antoniou, Tony, J. Raboud, Shuhang Shen, et al.. (2007). Risk Factors for Grade 3–4 Liver Enzyme Elevation in HIV and Hepatitis C Coinfected Patients on Combination Antiretroviral Therapy. AIDS Patient Care and STDs. 21(7). 469–478. 9 indexed citations

10.

Walker, Sandra A N, et al.. (2006). Management of Community-Acquired Pneumonia at a Tertiary-Care Teaching Hospital. The Canadian Journal of Hospital Pharmacy. 59(2). 4 indexed citations

11.

Rachlis, Anita. (2006). TMC114/r Tolerability in Treatment-experienced, Hepatitis B or C (HBV/HCV) Co-infected Patients in POWER 1 and 3. 2 indexed citations

12.

Raboud, Janet, Carol Major, Peggy Millson, et al.. (2005). Nonfinancial Factors Associated With Decreased Plasma Viral Load Testing in Ontario, Canada. JAIDS Journal of Acquired Immune Deficiency Syndromes. 39(3). 327–332. 9 indexed citations

13.

Tailor, Sandra A.N., Andrew E. Simor, William Cornish, et al.. (2004). Analysis of Spontaneous Reports of Hypoglycemia and Hyperglycemia Associated with Marketed Systemic Fluoroquinolones Made to the Canadian Adverse Drug Reaction Monitoring Program. The Canadian Journal of Hospital Pharmacy. 57(1). 5 indexed citations

14.

Burchell, Ann N., Liviana Calzavara, Ted Myers, et al.. (2003). Symptomatic primary HIV infection or risk experiences? Circumstances surrounding HIV testing and diagnosis among recent seroconverters. International Journal of STD & AIDS. 14(9). 601–608. 17 indexed citations

15.

Sullivan, John, Anita Rachlis, & Elizabeth J. Phillips. (2003). ‘Buffalo‐hump’ dermatitis: a hat trick of antiretroviral side‐effects. Contact Dermatitis. 48(3). 169–170. 1 indexed citations

16.

Singer, Joel, Anona Thorne, Peter Phillips, et al.. (1999). Predictors of survival and eradication of Mycobacterium avium complex bacteremia (MAC) in AIDS patients in the Canadian Randomized MAC Treatment Trial. AIDS. 13(5). 575–582. 5 indexed citations

17.

Shafran, Stephen D., James Talbot, Joel Singer, et al.. (1998). Does In Vitro Susceptibility to Rifabutin and Ethambutol Predict the Response to Treatment of Mycobacterium avium Complex Bacteremia with Rifabutin, Ethambutol, and Clarithromycin?. Clinical Infectious Diseases. 27(6). 1401–1405. 16 indexed citations

18.

Rachlis, Anita. (1998). Neurologic manifestations of HIV infection. Postgraduate Medicine. 103(3). 147–161. 10 indexed citations

19.

El‐Helou, Philippe, et al.. (1997). Mycobacterium xenopiInfection in Patients with Human Immunodeficiency Virus Infection. Clinical Infectious Diseases. 25(2). 206–210. 51 indexed citations

20.

Gill, M. John, et al.. (1991). Five cases of erroneously diagnosed HIV infection.. PubMed Central. 145(12). 1593–5. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact